Russia / Biocad Ramps up Sputnik V Manufacturing; Unlicensed Remdesivir Generics; Chinese Vaccine Rejection
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
Address: Glazovsky per., building 7, office 17, 119002 Moscow,Russia
Tel: +74 95 9333830 / 32
Web: http://www.zambonpharma.com/it/zspa-homespa/zc-home/entry/0/241/0/default.html
Zambon Company, an industrial holding owned by the Zambon family, is an Italian venture with over 100 years of experience in the chemical and pharmaceuticals industries.
The company operates within the pharmaceutical market in three strategic areas: Respiratory (42%), Pain Management (34%) and Woman Health Care (24%).
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities,…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this…
You took over this organization just three months ago, having previously headed businesses in industries as diverse…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the…